Interferon-γ: an overview of signals, mechanisms and functions
The DOI matches its Crossref record; 433 of the 443 references it cites were found in a registry or an index.
Abstract
Interferon-γ (IFN-γ) coordinates a diverse array of cellular programs through transcriptional regulation of immunologically relevant genes. This article reviews the current understanding of IFN-γ ligand, receptor, ignal transduction, and cellular effects with a focus on macrophage responses and to a lesser extent, responses from other cell types that influence macrophage function during infection. The current model for IFN-γ signal transduction is discussed, as well as signal regulation and factors conferring signal specificity. Cellular effects of IFN-γ are described, including up-regulation of pathogen recognition, antigen processing and presentation, the antiviral state, inhibition of cellular proliferation and effects on apoptosis, activation of microbicidal effector functions, immunomodulation, and leukocyte trafficking. In addition, integration of signaling and response with other cytokines and pathogen-associated molecular patterns, such as tumor necrosis factor-α, interleukin-4, type I IFNs, and lipopolysaccharide are discussed.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Indeed, the proteins encoded by these genes are all reported to be part of a signaling cascade upstream of interferon regulatory factor 1 (IRF1) and downstream of interferon-γ (IFNγ; ref. 50).”
From scPerturb: harmonized single-cell perturbation data (2024) · cites this paper as [50]
Citations
Cites
Darnell, J. E., Kerr, L. M., & Stark, G. R. (1994) · Science · doi:10.1126/science.8197455 · Cited by 6,080
Cancer immunoediting: from immunosurveillance to tumor escape
Dunn, G. P., Bruce, A. T., Ikeda, H., Old, L. J., & Schreiber, R. D. (2002) · Nature Immunology · doi:10.1038/ni1102-991 · Cited by 5,393
NITRIC OXIDE AND MACROPHAGE FUNCTION
MacMicking, J., Xie, Q.-W., & Nathan, C. (1997) · Annual Review of Immunology · doi:10.1146/annurev.immunol.15.1.323 · Cited by 4,211 · cited 3×
“, peroxynitrite) to mediate cytotoxicity by a wide variety of mechanisms [281, 370, 371].”
InfluentialDarnell, J. E. (1997) · Science · doi:10.1126/science.277.5332.1630 · Cited by 3,979
HOW CELLS RESPOND TO INTERFERONS
Stark, G. R., Kerr, I. M., Williams, B. R. G., Silverman, R. H., & Schreiber, R. D. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.227 · Cited by 3,932 · cited 2×
“, Stat1:Stat1:IRF-9, Stat1:Stat2:IRF-9) form during signaling [102, 116–118].”
Virus interference. I. the interferon
Isaacs, A., & Lindenmann, J. (1957) · Proceedings of the Royal Society of London. Series B - Biological Sciences · doi:10.1098/rspb.1957.0048 · Cited by 3,451
Toll-like receptors in the induction of the innate immune response
Aderem, A., & Ulevitch, R. J. (2000) · Nature · doi:10.1038/35021228 · Cited by 3,064
CELLULAR RESPONSES TO INTERFERON-γ
Boehm, U., Klamp, T., Groot, M., & Howard, J. C. (1997) · Annual Review of Immunology · doi:10.1146/annurev.immunol.15.1.749 · Cited by 2,890 · cited 7×
“Chaperones such as tapasin and GP96 implicated in aiding in the efficient assembly of peptide:MHC I complexes are also up-regulated by IFN- [4, 309, 310].”
InfluentialPeroxynitrite oxidation of sulfhydryls.
Radi, R., Beckman, J. S., Bush, K. M., & Freeman, B. A. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(20)64313-7 · Cited by 2,490
Functional Role of Type I and Type II Interferons in Antiviral Defense
Müller, U., Steinhoff, U., Reis, L. F. L., Hemmi, S., Pavlovic, J., Zinkernagel, R. M., & Aguet, M. (1994) · Science · doi:10.1126/science.8009221 · Cited by 2,453 · cited 2×
“fend against a broad spectrum of pathogens [60, 61].”
Research works printed but not linked: 1
- Dey, 1999, Gamma interferon induces expression of Mad1 gene in macrophage, which inhibits colony-stimulating factor-1-dependent mitogenesis, J. Cell. Biochem., 72, 232, 10.1002/(sici)1097-4644(19990201)72:2<232::aid-jcb7>3.0.co;2-0 · DOI
Cited by
Items 701–800 of 1,014
An Immune Atlas of T Cells in Transplant Rejection: Pathways and Therapeutic Opportunities
Short, S., Lewik, G., & Issa, F. (2023) · Transplantation · doi:10.1097/tp.0000000000004572 · Cited by 68
Papathanasiou, E., Teles, F., Griffin, T., Arguello, E., Finkelman, M., Hanley, J., & Theoharides, T. C. (2014) · Journal of Periodontal Research · doi:10.1111/jre.12078 · Cited by 63
JAK-STAT signaling in hepatic fibrosis
Mair, M., Blaas, L., Österreicher, C. H., Casanova, E., & Eferl, R. (2011) · Frontiers in bioscience · doi:10.2741/3886 · Cited by 69
Nii, T., Isobe, N., & Yoshimura, Y. (2014) · Theriogenology · doi:10.1016/j.theriogenology.2014.02.002 · Cited by 71
Mitsuhashi, A., Goto, H., Kuramoto, T., Tabata, S., Yukishige, S., Abe, S., Hanibuchi, M., Kakiuchi, S., Saijo, A., Aono, Y., et al. (2013) · American Journal Of Pathology · doi:10.1016/j.ajpath.2013.01.030 · Cited by 66
Martín, S., Mohanty, B. P., Cash, P., Houlihan, D. F., & Secombes, C. J. (2007) · PROTEOMICS · doi:10.1002/pmic.200700020 · Cited by 69
Williams, A. S., Richards, P. J., Thomas, E., Carty, S., Nowell, M. A., Goodfellow, R., Dent, C., Williams, B. D., Jones, S. A., & Topley, N. (2007) · Arthritis & Rheumatism · doi:10.1002/art.22732 · Cited by 71
Guo, Y. E., Riley, K. J., Iwasaki, A., & Steitz, J. A. (2014) · Molecular Cell · doi:10.1016/j.molcel.2014.03.025 · Cited by 66
“immune responses (Schroder et al., 2004; Suzuki et al., 2008).”
BackgroundAbad, C., Juarranz, Y., Martínez, C., Arranz, A., Rosignoli, F., García-Gómez, M., Leceta, J., & Gomariz, R. P. (2005) · Inflammatory Bowel Diseases · doi:10.1097/01.mib.0000171872.70738.58 · Cited by 68
Ho, J., Pelzel, C., Begitt, A., Mee, M., Elsheikha, H. M., Scott, D. J., & Vinkemeier, U. (2016) · PLOS Biology · doi:10.1371/journal.pbio.2000117 · Cited by 64
Inflammatory, cardio-metabolic and diabetic profiling of chronic schizophrenia
Balõtšev, R., Koido, K., Vasar, V., Janno, S., Kriisa, K., Mahlapuu, R., Ljubajev, U., Parksepp, M., Veiksaar, P., Volke, V., et al. (2017) · European Psychiatry · doi:10.1016/j.eurpsy.2016.05.010 · Cited by 64
“IFN-g is an important activator of macrophages, its aberrant expression has been associated with a number of auto-inflammatory and autoimmune diseases, and it is critical for innate and adaptive immunity against viral and intracellular bacterial infections [48].”
BackgroundVisualizing Single-Cell Secretion Dynamics with Single-Protein Sensitivity
McDonald, M. P., Gemeinhardt, A., König, K., Piliarik, M., Schaffer, S., Völkl, S., Aigner, M., Mackensen, A., & Sandoghdar, V. (2017) · Nano Letters · doi:10.1021/acs.nanolett.7b04494 · Cited by 66
Hwang, M., & Bergmann, C. C. (2018) · Journal of Virology · doi:10.1128/jvi.01901-17 · Cited by 64
Epigenetics, DNA Organization, and Inflammatory Bowel Disease
Ray, G., & Longworth, M. S. (2018) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izy330 · Cited by 71
Lavoie, J., Latorre, C. C., Lavoie‐Lamoureux, A., Moran, K., Lutz, S., Picandet, V., Jean, D., & Marcoux, M. (2011) · Journal of Veterinary Internal Medicine · doi:10.1111/j.1939-1676.2010.0664.x · Cited by 66
Inducible Nitric Oxide Synthase Is Not Essential for Control ofTrypanosoma cruziInfection in Mice
Cummings, K. L., & Tarleton, R. L. (2004) · Infection and Immunity · doi:10.1128/iai.72.7.4081-4089.2004 · Cited by 66
Qi, Y.-T., Zhang, F.-L., Tian, S.-Y., Wu, H.-Q., Zhao, Y., Zhang, X.-W., Liu, Y.-L., Fu, P., Amatore, C., & Huang, W.-H. (2024) · Nature Nanotechnology · doi:10.1038/s41565-023-01575-0 · Cited by 65
Expression Regulation and Function of T-Bet in NK Cells
Huang, C., & Bi, J. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.761920 · Cited by 73
Role of Cytokines in Vitiligo: Pathogenesis and Possible Targets for Old and New Treatments
Custurone, P., Bartolomeo, L. D., Irrera, N., Borgia, F., Altavilla, D., Bitto, A., Pallio, G., Squadrito, F., & Vaccaro, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222111429 · Cited by 76
Systemic maternal inflammation promotes ASD via IL-6 and IFN-γ
Majerczyk, D., Ayad, E., Brewton, K. L., Saing, P., & Hart, P. C. (2022) · Bioscience Reports · doi:10.1042/bsr20220713 · Cited by 72
MSC and Tumors: Homing, Differentiation, and Secretion Influence Therapeutic Potential
D’souza, N., Burns, J. S., Grisendi, G., Candini, O., Veronesi, E., Piccinno, S., Horwitz, E. M., Paolucci, P., Conte, P., & Dominici, M. (2012) · Advances in Biochemical Engineering/Biotechnology · doi:10.1007/10_2012_150 · Cited by 61
Lengacher, C. A., Kip, K. E., Post-White, J., Fitzgerald, S., Newton, C., Barta, M., Jacobsen, P. B., Shelton, M. M., Moscoso, M., Johnson-Mallard, V., et al. (2013) · Biological Research For Nursing · doi:10.1177/1099800411419245 · Cited by 65
Kramer, J. M. (2014) · Cytokine · doi:10.1016/j.cyto.2014.02.009 · Cited by 70
Ren, Y., Zhang, Y., Liu, R. Z., Fenstermacher, D. A., Wright, K. L., Teer, J. K., & Wu, J. (2013) · Scientific Reports · doi:10.1038/srep03042 · Cited by 71
Dolan, S. M., Hollegaard, M. V., Merialdi, M., Betrán, A. P., Allen, T., Abelow, C., Nace, J., Lin, B. K., Khoury, M. J., Ioannidis, J. P. A., et al. (2010) · Public Health Genomics · doi:10.1159/000294202 · Cited by 68
Elomaa, A.-P., Niskanen, L., Herzig, K.-H., Viinamäki, H., Hintikka, J., Koivumaa-Honkanen, H., Honkalampi, K., Valkonen-Korhonen, M., Harvima, I. T., & Lehto, S. M. (2012) · BMC Psychiatry · doi:10.1186/1471-244x-12-2 · Cited by 62
“Its biological responses are closely integrated with the other cytokine mechanisms, with signaling pathways especially cross-talking with IFN-a [17].”
BackgroundCerebral malaria: gamma-interferon redux
Hunt, N. H., Ball, H. J., Hansen, A. M., Khaw, L. T., Guo, J. T., Bakmiwewa, S. M., Mitchell, A. J., Combes, V., & Grau, G. E. (2014) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2014.00113 · Cited by 71
“This leads to activation of STAT1, which homodimerizes, enters the nucleus and initiates the transcription of Interferon Response Factors that induce the expression of a wide range of genes (Schroder et al., 2004; Saha et al., 2010).”
BackgroundNiu, C. S., Jin, H., Li, M., Xu, J., Xu, D., Hu, J., He, H., Li, W., & Cui, J. (2015) · BMC Immunology · doi:10.1186/s12865-015-0124-x · Cited by 72
“which inhibit tumor angiogenesis and recruit CXCR3bearing effector cells to tumor sites [29, 30].”
BackgroundVergis, N., Khamri, W., Beale, K., Sadiq, F., Aletrari, M.-O., Moore, C., Atkinson, S. R., Bernsmeier, C., Possamai, L. A., Petts, G., et al. (2016) · Gut · doi:10.1136/gutjnl-2015-310378 · Cited by 65
Smith, J. N. P., Kanwar, V. S., & MacNamara, K. C. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00330 · Cited by 73
“IFNγ stimulates MΦ cytokine production (Figure 1f) and antigen presentation (91), therefore, it stands to reason that MΦs may contribute to IFNγ-driven AA pathogenesis.”
BackgroundWang, C., Feng, L., Jia-yan, S., Cui, L., Liu, D., Yan, J., Ding, C., Tan, X., & Jia, X. (2017) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2017.06.014 · Cited by 67
Lee, H.-R., Son, C., Koh, E.-K., Bae, J.-H., Kang, C., Yang, K., & Park, Y.-S. (2017) · Scientific Reports · doi:10.1038/s41598-017-09259-1 · Cited by 70
Inflammation and Prostate Cancer
Tewari, A. K., Stockert, J. A., Yadav, S. S., Yadav, K. K., & Khan, I. (2018) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-95693-0_3 · Cited by 68
Paracrine costimulation of IFN-γ signaling by integrins modulates CD8 T cell differentiation
Krummel, M. F., Mahale, J. N., Uhl, L. F. K., Hardison, E. A., Mujal, A. M., Mazet, J. M., Weber, R. J., Gartner, Z. J., & Gérard, A. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1804556115 · Cited by 67
Inhibition of IFN-γ-Induced STAT1 Tyrosine Phosphorylation by Human CMV Is Mediated by SHP2
Baron, M., & Davignon, J.-L. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.8.5530 · Cited by 61
“IFN- up-regulates a number of other genes involved in Ag presentation, including peptidases (13, 14).”
BackgroundHepcidin expression in human airway epithelial cells is regulated by interferon-γ
Frazier, M. D., Mamo, L. B., Ghio, A. J., & Turi, J. L. (2011) · Respiratory Research · doi:10.1186/1465-9921-12-100 · Cited by 64
“IFN-g classically signals through the JAK-STAT pathway [32], such that binding to the IFN-g receptor phosphorylates JAK2.”
BackgroundKhanmohammadi, S., Rezaei, N., Khazaei, M., & Shirkani, A. (2021) · Journal of Clinical Immunology · doi:10.1007/s10875-021-01166-5 · Cited by 65
Cytokines as Biomarkers in Systemic Lupus Erythematosus: Value for Diagnosis and Drug Therapy
Idborg, H., & Oke, V. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222111327 · Cited by 73
Cytokines in Abdominal Aortic Aneurysm: Master Regulators With Clinical Application
Пученкова, О. А., Soldatov, V. O., Белых, А. Е., Bushueva, O., Piavchenko, G. A., Venediktov, A. A., Shakhpazyan, N. K., Deykin, A. V., Корокин, М. В., & Pokrovskiy, M. V. (2022) · Biomarker Insights · doi:10.1177/11772719221095676 · Cited by 65
The Use of Janus Kinase Inhibitors for Lichen Planus: An Evidence-Based Review
Abduelmula, A., Bagit, A., Mufti, A., Yeung, K. C. Y., & Yeung, J. (2023) · Journal of Cutaneous Medicine and Surgery · doi:10.1177/12034754231156100 · Cited by 64
Decline in nitrosative stress drives antibiotic persister regrowth during infection
Ronneau, S., Michaux, C., & Hélaine, S. (2023) · Cell Host & Microbe · doi:10.1016/j.chom.2023.05.002 · Cited by 68
SEPTIN2 suppresses an IFN-γ-independent, proinflammatory macrophage activation pathway
Fu, B., Xiong, Y., Sha, Z., Xue, W., Xu, B., Tan, S., Guo, D., Lin, F., Wang, L., Ji, J., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-43283-2 · Cited by 68
He, H., Genovese, K. J., Swaggerty, C. L., MacKinnon, K. M., & Kogut, M. H. (2011) · Developmental & Comparative Immunology · doi:10.1016/j.dci.2011.11.006 · Cited by 70
“Production of IFN-c was initially reported only in CD4+ Th1 lymphocytes, CD8+ cytotoxic lymphocytes, and natural killer (NK) cells (Schroder et al., 2004).”
BackgroundIRF9 is a Key Factor for Eliciting the Antiproliferative Activity of IFN-α
Tsuno, T., Mejido, J., Zhao, T., Schmeisser, H., Morrow, A., & Zoon, K. C. (2009) · Journal of Immunotherapy · doi:10.1097/cji.0b013e3181ad4092 · Cited by 64
“The activated Stat1 assembles as homodimers and translocates to the nucleus followed by binding to the GAS element.(1,2,4) Thus, it has been reported that the JAK-STAT pathway is fundamentally required for initial activation of IFN signaling.”
BackgroundInfluentialNetwork Topologies and Dynamics Leading to Endotoxin Tolerance and Priming in Innate Immune Cells
Fu, Y., Glaros, T., Zhu, M., Wang, P., Wu, Z., Tyson, J. J., Li, L., & Xing, J. (2012) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1002526 · Cited by 69
“Priming of macrophage by a low dose IFN-c promotes STAT1 expression, which may synergistically cooperate with NFkB to give boosted cytokine expression to secondary stimulation by LPS [55,56].”
Inflammatory mechanisms of endometritis
Woodward, E. M., & Troedsson, M. H. T. (2014) · Equine Veterinary Journal · doi:10.1111/evj.12403 · Cited by 77
Bank, S., Andersen, P. S., Burisch, J. M., Pedersen, N. K., Roug, S., Galsgaard, J., Turino, S. Y., Brodersen, J. B., Rashid, S., Rasmussen, B. K., et al. (2017) · The Pharmacogenomics Journal · doi:10.1038/tpj.2016.84 · Cited by 64
Hu, X., Park-Min, K.-H., Ho, H. H., & Ivashkiv, L. B. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.6.3637 · Cited by 61
“As with most cytokines that use the Jak-Stat pathway, two Jaks, Jak1 and Jak2, participate in IFN- signaling (1).”
BackgroundInfluentialReveneau, N., Crane, D. D., Fischer, E. R., & Caldwell, H. D. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.5.1787-1793.2005 · Cited by 64
Creighton, C. J., Bromberg-White, J. L., Misek, D. E., Monsma, D. J., Brichory, F., Kuick, R., Giordano, T. J., Gao, W., Omenn, G. S., Webb, C. P., et al. (2005) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-04-0189 · Cited by 61
Hammer, Q., Dunst, J., Christ, W., Picarazzi, F., Wendorff, M., Momayyezi, P., Huhn, O., Netskar, H., Maleki, K. T., García, M., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.110503 · Cited by 64
Vázquez, N., Greenwell‐Wild, T., Rekka, S., Orenstein, J. M., & Wahl, S. M. (2006) · Journal of Leukocyte Biology · doi:10.1189/jlb.0306206 · Cited by 69
“IFN- , an immunomodulator with known macrophage activating properties [42–44], reportedly has conflicting effects in resolution of both M.”
BackgroundGene therapy for malignant glioma
Okura, H., Smith, C. A., & Rutka, J. T. (2014) · Molecular and Cellular Therapies · doi:10.1186/2052-8426-2-21 · Cited by 68
“Similar to IFN-β, the type II interferon gene, IFN-γ, is also an immune stimulatory cytokine produced by NK cells, dendritic cells, and activated T-lymphocytes [69,170].”
MethodMašić, A., Booth, J. S., Mutwiri, G., Babiuk, L. A., & Zhou, Y. (2009) · Journal of Virology · doi:10.1128/jvi.00926-09 · Cited by 63
“IFN-, produced by CD4 T-helper cell type 1 (Th1) lymphocytes, CD8 cytotoxic lymphocytes, and NK cells (1), is the major immunomodulator that coordinates the immune responses and establishes an antiviral state of longer duration ( 32 ).”
BackgroundMonzel, C., Schmidt, D., Kleusch, C., Kirchenbüechler, D., Seifert, U., Smith, A., Sengupta, K., & Merkel, R. (2015) · Nature Communications · doi:10.1038/ncomms9162 · Cited by 63
Shang, L., & Tomasi, T. B. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m509901200 · Cited by 63
Immune regulation of Rab proteins expression and intracellular transport
Pei, G., Bronietzki, M., & Gutierrez, M. G. (2012) · Journal of Leukocyte Biology · doi:10.1189/jlb.0212076 · Cited by 69
“This IFN, originally called macrophage-activating factor, is the key protective cytokine for macrophages, leading to the induction of diverse antimicrobial activities [20].”
BackgroundZhou, F., Chen, J., & Zhao, K. (2013) · Journal of General Virology · doi:10.1099/vir.0.054486-0 · Cited by 65
“IFN-c is well known to have antiviral, immuneregulatory and anti-tumour properties (Schroder et al., 2004).”
BackgroundRadiosensitivity index emerges as a potential biomarker for combined radiotherapy and immunotherapy
Dai, Y.-H., Wang, Y.-F., Shen, P., Lo, C., Yang, J.-F., Lin, C., Chao, H., & Huang, W. (2021) · npj Genomic Medicine · doi:10.1038/s41525-021-00200-0 · Cited by 64
Inflammatory Cytokines Shape an Altered Immune Response During Myeloid Malignancies
Camacho, V., Kuznetsova, V., & Welner, R. S. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.772408 · Cited by 68
Effects of Oleuropein and Hydroxytyrosol on Inflammatory Mediators: Consequences on Inflammaging
Pojero, F., Aiello, A., Gervasi, F., Caruso, C., Ligotti, M. E., Calabrò, A., Procopio, A., Candore, G., Accardi, G., & Allegra, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms24010380 · Cited by 65
Ghita, L., Yao, Z., Xie, Y., Durán, V., Cagirici, H. B., Samir, J., Osman, I., Rebellón-Sánchez, D. E., Rojas, O. L. A., Sanz, A. M., et al. (2023) · Nature Immunology · doi:10.1038/s41590-023-01654-3 · Cited by 67
“Whereas IFN signaling genes, such as IRF1 and STAT1 , were upregulated in all APC subtypes of SDp compared with the D group, down-stream IFN-stimulated genes (ISGs), including IFIT1 , ISG15 , MARCKS and APOBEC3A , were upregulated in cDCs and B cells but downregulated in monocytes (particularly nonclassical; Fig.”
BackgroundInfluentialvan Dijk, F., Olinga, P., Poelstra, K., & Beljaars, L. (2015) · Frontiers in Medicine · doi:10.3389/fmed.2015.00072 · Cited by 60
“These complexes are able to bind to IFN-stimulated response element (ISRE) promoter regions in target genes to regulate transcription of, for example, inducible nitric oxide synthase (iNOS), IRF-2, and IFNβ (14).”
BackgroundInfluentialMüller, S. C., März, R., Schmolz, M., Drewelow, B., Eschmann, K., & Meiser, P. (2012) · Phytotherapy Research · doi:10.1002/ptr.4678 · Cited by 68
“Interleukin-2 and IFNg both pertain to the Th1-type of immune response (Schroder et al., 2004), whereas IL-5 and IL-13 mark the Th2-driven reactions (O’Byrne, 2006).”
BackgroundIdiopathic Pulmonary Fibrosis: Natural History and Prognosis
Noble, P. W. (2006) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2005.08.003 · Cited by 65
Chicken interferons, their receptors and interferon-stimulated genes
Goossens, K. E., Ward, A. C., Lowenthal, J. W., & Bean, A. G. D. (2013) · Developmental & Comparative Immunology · doi:10.1016/j.dci.2013.05.020 · Cited by 65
Zhang, J., Qian, X., Ning, H., Yang, J., Xiong, H., & Liu, J. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.100818 · Cited by 68
Sarrazin, S., Bonnaffé, D., Lubineau, A., & Lortat‐Jacob, H. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m507729200 · Cited by 69
A Role for Matrix Metalloproteinase 9 in IFNγ-Mediated Injury in Developing Lungs
Harijith, A. K., Choo-Wing, R., Çataltepe, S., Yasumatsu, R., Aghai, Z. H., Janér, J., ANDERSSON, S. M., Homer, R., & Bhandari, V. (2011) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2010-0058oc · Cited by 62
Jin, S. H., Choi, D., Chun, Y.-J., & Noh, M. (2014) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2014.08.019 · Cited by 65
Evasion of the Mucosal Innate Immune System by Herpes Simplex Virus Type 2
Peng, T., Zhu, J., Klock, A. M., Phasouk, K., Huang, M.-L. W., Koelle, D. M., Wald, A., & Corey, L. (2009) · Journal of Virology · doi:10.1128/jvi.00939-09 · Cited by 62
Bank, S., Andersen, P. S., Burisch, J., Pedersen, N., Roug, S., Galsgaard, J., Ydegaard Turino, S., Broder Brodersen, J., Rashid, S., Kaiser Rasmussen, B., et al. (2015) · PLOS ONE · doi:10.1371/journal.pone.0145302 · Cited by 60
Immunomodulatory Effects of Chitotriosidase Enzyme
Elmonem, M. A., van den Heuvel, L. P., & Levtchenko, E. N. (2016) · Enzyme Research · doi:10.1155/2016/2682680 · Cited by 76
Macrophages: Key regulators of steady-state and demand-adapted hematopoiesis
McCabe, A. F., & MacNamara, K. C. (2016) · Experimental Hematology · doi:10.1016/j.exphem.2016.01.003 · Cited by 66
“24 [87] Schroder K, Hertzog PJ, Ravasi T, Hume DA.”
BackgroundWEDEKIND, L. E., & Belkacemi, L. (2016) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2016.05.011 · Cited by 62
Wan, Q., Yang, C., Rao, Y., Liao, Z., & Su, J. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00189 · Cited by 62
Zuo, X., Deguchi, Y., Xu, W., Liu, Y., Li, H. S., Wei, D., Tian, R., Chen, W., Xu, M., Yang, Y., et al. (2019) · Gastroenterology · doi:10.1053/j.gastro.2019.03.018 · Cited by 64
Diorio, C., Shaw, P. A., Pequignot, E., Orlenko, A., Chen, F., Aplenc, R., Barrett, D. M., Bassiri, H., Behrens, E., DiNofia, A. M., et al. (2020) · Blood Advances · doi:10.1182/bloodadvances.2020002592 · Cited by 61
Patel, K. R., Lawson, D. H., Kudchadkar, R. R., Carthon, B. C., Oliver, D. E., Okwan-Duodu, D. K., Ahmed, R., & Khan, M. K. (2015) · Neuro-Oncology · doi:10.1093/neuonc/nov093 · Cited by 62
Phytochemicals as Immunomodulatory Molecules in Cancer Therapeutics
Paudel, S., Mishra, N., & Agarwal, R. (2023) · Pharmaceuticals · doi:10.3390/ph16121652 · Cited by 68
“Fraker et al. showed that the oral administration of retinol in wild-type BALB/c and congenitally athymic BALB/c mice can enhance the cytotoxic activity of NK cells in the spleen within an hour of treatment [141].”
BackgroundKim, H. S., Kim, D. C., Kim, H.-M., Kwon, H., Kwon, S. J., Kang, S., Kim, S. C., & Choi, G.-E. (2015) · Scientific Reports · doi:10.1038/srep13414 · Cited by 68
Mazzardo‐Martins, L., Martins, D. F., Stramosk, J., Cidral‐Filho, F. J., & Santos, A. R. S. (2012) · Neuroscience · doi:10.1016/j.neuroscience.2012.09.020 · Cited by 63
“, 2004), and decreases the activity and expression of anti-inflammatory IL-10 (Herrero et al., 2003; Schroder et al., 2004; Lin et al., 2008).”
BackgroundMarchi, L. F., Sesti‐Costa, R., Ignacchiti, M. D. C., Chedraoui-Silva, S., & Mantovani, B. (2013) · International Immunopharmacology · doi:10.1016/j.intimp.2013.12.010 · Cited by 69
Transcriptomic analysis of mononuclear phagocyte differentiation and activation
Hume, D. A., & Freeman, T. C. (2014) · Immunological Reviews · doi:10.1111/imr.12211 · Cited by 58
Self-citationChemical and genetic control of IFNγ‐induced MHCII expression
Wijdeven, R. H. M., van Luijn, M. M., Wierenga‐Wolf, A. F., Akkermans, J. J. L. L., van den Elsen, P. J., Hintzen, R. Q., & Neefjes, J. (2018) · EMBO Reports · doi:10.15252/embr.201745553 · Cited by 66
Lolansen, S. D., Rostgaard, N., Oernbo, E. K., Juhler, M., Simonsen, A. H., & MacAulay, N. (2021) · Disease Markers · doi:10.1155/2021/8834822 · Cited by 61
“IFN-γ is secreted primarily by immune cells [85, 86].”
BackgroundIFN-γ and STAT1 Arrest Monocyte Migration and Modulate RAC/CDC42 Pathways
Hu, Y., Hu, X., Boumsell, L., & Ivashkiv, L. B. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.12.8057 · Cited by 70
“IFN- is a potent activator of monocytes/macrophages that promotes microbial killing, Ag presentation, and production of inflammatory mediators (9).”
BackgroundYao, Y., Xu, Q., Kwon, M.-J., Matta, R., Liu, Y., Hong, S.-C., & Chang, C.-H. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.1.70 · Cited by 62
“Conversely, LPS pretreatment is able to promote the IFN- signaling pathway through triggering type I IFN production (33).”
Vitenberga-Verza, Z., Pilmane, M., Šerstņova, K., Melderis, I., Gontar, Ł., Kochański, M., Drutowska, A., Maróti, G., & Prieto‐Simón, B. (2022) · Pathogens · doi:10.3390/pathogens11030372 · Cited by 60
Natural killer cells suppress full cycle HCV infection of human hepatocytes
Wang, S. ‐., Huang, C. ‐., Ye, L., Wang, X., Li, S., Wang, Y. ‐., Liang, H., Huang, X. ‐., & Ho, W. Z. (2008) · Journal of Viral Hepatitis · doi:10.1111/j.1365-2893.2008.01014.x · Cited by 60
TLR3 drives IRF6‐dependent IL‐23p19 expression and p19/EBI3 heterodimer formation in keratinocytes
Ramnath, D., Tunny, K. A., Hohenhaus, D. M., Pitts, C. M., Bergot, A., Hogarth, P. M., Hamilton, J. A., Kapétanovic, R., Sturm, R. A., Scholz, G. M., et al. (2015) · Immunology and Cell Biology · doi:10.1038/icb.2015.77 · Cited by 61
Strategies to improve the immunosuppressive properties of human mesenchymal stem cells
Lee, M. W., Ryu, S., Kim, D. S., Sung, K. W., Koo, H. H., & Yoo, K. H. (2015) · Stem Cell Research & Therapy · doi:10.1186/s13287-015-0178-y · Cited by 69
“IFN-γ was initially believed to be secreted only by CD4 Th1 lymphocytes, CD8 cytotoxic T lymphocytes, and NK cells; however, other types of cells, including B cells, NK T cells, and IL-12-stimulated APCs, can also produce IFN-γ [107–109].”
BackgroundThe enhanced effect of lupeol on the destruction of gastric cancer cells by NK cells
Wu, X., Liu, J., Lu, X., Chen, F., Zhou, Z.-H., Wang, T., Zhu, S.-P., & Fei, S. (2013) · International Immunopharmacology · doi:10.1016/j.intimp.2013.04.017 · Cited by 60
Ni, C., Wu, P., Zhu, X., Ye, J., Zhang, Z., Chen, Z., Zhang, T., Zhang, T., Wang, K., Wu, D., et al. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.04.029 · Cited by 66
The Association of Cytokines with Severe Dengue in Children
Mangione, J. N. A., Huy, N. T., Lan, N. T. P., Mbanefo, E. C., Ha, T. T. N., Lam, B., Nga, C. T. P., Tuong, V. V., Dat, T. V., Thúy, T. T., et al. (2014) · Tropical Medicine and Health · doi:10.2149/tmh.2014-09 · Cited by 60
“Its main effects are monocyte and macrophage activation [25].”
BackgroundNontuberculous mycobacterial infections in children with inborn errors of the immune system
Haverkamp, M. H., van de Vosse, E., & van Dissel, J. T. (2013) · Journal of Infection · doi:10.1016/j.jinf.2013.09.024 · Cited by 60
Jiang, M., Peng, X., Fang, J. S., Cui, H., Yu, Z., & Chen, Z. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms16046945 · Cited by 62
“IFN-γ, mainly produced by T cells and NK cells, is a regulator of numerous immunological functions such as immunomodulation and leukocyte trafficking [26].”
BackgroundTryptophan Depletion and the Kinase GCN2 Mediate IFN-γ–Induced Autophagy
Fougeray, S., Mami, I., Bertho, G., Beaune, P. H., Thervet, É., & Pallet, N. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1201214 · Cited by 72
Cervical Carcinogenesis and Immune Response Gene Polymorphisms: A Review
Mehta, A., Mooij, M., Branković, I., Ouburg, S., Morré, S. A., & Jordanova, E. S. (2017) · Journal of Immunology Research · doi:10.1155/2017/8913860 · Cited by 65
Quatrini, L., Wieduwild, É., Guia, S., Bernat, C., Glaichenhaus, N., Vivier, É., & Ugolini, S. (2017) · The Journal of Experimental Medicine · doi:10.1084/jem.20171048 · Cited by 61
“IFN-γ is an important endogenous regulator of the immune response (Schroder et al., 2004).”
Background
Metadata
- Authors
- Schroder, K., Hertzog, P. J., Ravasi, T., & Hume, D. A.
- Affiliations
- The University of Queensland (AU)
- Monash Medical Centre (AU)
- Corresponding author
- Hume, David A
- Venue
- Journal of Leukocyte Biology
- Publisher
- Oxford University Press (OUP)
- Published
- 2003-10-02
- Volume
- 75
- Issue
- 2
- Pages
- 163-189
- ISSN
- 0741-5400 (ISSN-L)
- 1938-3673
- OpenAlex
- W2167017590
- Cited by
- 4,120
- References
- 443
- Citations by year
- 2026: 141 · 2025: 166 · 2024: 208 · 2023: 231 · 2022: 229 · 2021: 252 · 2020: 243 · 2019: 213 · 2018: 193 · 2017: 225 · 2016: 236 · 2015: 246 · 2014: 209 · 2013: 224 · 2012: 195
- FWCI
- 6.62
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Leukocyte Biology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Cytokine Signaling Pathways and Interactions
- Life Sciences › Immunology and Microbiology › Immunology › interferon and immune responses
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Keywords
- interferon-gamma, IFN-gamma receptor, signal transduction, macrophage response, transcriptional regulation, antigen processing and presentation, antiviral state, apoptosis, immunomodulation, leukocyte migration, cytokine signaling, pathogen-associated molecular patterns
- MeSH terms
- Animals, Gene Expression Regulation, Humans, Inflammation, Interferon-gamma, Macrophages, Signal Transduction, Receptor Cross-Talk
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.